About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
Not Voodoo

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
Realizations in Biostatistics
ChemSpider Blog
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Eye on FDA
Chemical Forums
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa

Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
Gene Expression (I)
Gene Expression (II)
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net

Medical Blogs
DB's Medical Rants
Science-Based Medicine
Respectful Insolence
Diabetes Mine

Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem

Politics / Current Events
Virginia Postrel
Belmont Club
Mickey Kaus

Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« A Deuterium Deal | Main | Random Questions »

June 2, 2009

Blog Contestiness

Email This Entry

Posted by Derek

Voting has started on that 3Quarks science blog prize - here's the voting page. I have several posts on their nominees list, so I'll probably be diluted a bit, but please vote for your favorites (and discover some blogs that you probably haven't heard about).

Comments (5) + TrackBacks (0) | Category: Blog Housekeeping


1. Anonymous on June 2, 2009 2:23 PM writes...

I think I speak for many of Derek's regular readers as I express my hope that he wins this prize. I wonder if we could avoid dilution by agreeing here to vote for one post in particular, or if this would be considered unethical?

Permalink to Comment

2. Bob on June 2, 2009 3:25 PM writes...

I agree with anon.
my fav is always "thing I won't work with"
but i will wait til tomorrow and see if there is agreement.

I never miss In the pipeline.

and the heck with "unethical"...lets go for it.

Permalink to Comment

3. eugene on June 3, 2009 5:55 AM writes...

Ack, Derek! What shameless self-promotion! How can we ever trust your integrity again after all this? I thought you were different, but you are like the rest of the evil big pharma outfits! I will read 'In the Pipeline' in a cynical manner from now on...

At least you could have come up with a creative anagram (like 'Reeked Owl' for Derek Lowe) of your name instead of posting as 'Anonymous' or 'Bob' :)

P.S. Just kidding... Already voted for you

Permalink to Comment

4. Derek Lowe on June 3, 2009 7:12 AM writes...

Good grief, here I am at my age, and I never realized that my name was an anagram for "reeked owl." The things one learns. . .

Permalink to Comment

5. Anonymous on June 3, 2009 9:15 AM writes...

Well, at any matter, you can view the results before voting (I could anyway) so you can vote for your favorite, or vote for the column that has the most votes so far.

Permalink to Comment


Remember Me?


Email this entry to:

Your email address:

Message (optional):

The Last Post
The GSK Layoffs Continue, By Proxy
The Move is Nigh
Another Alzheimer's IPO
Cutbacks at C&E News
Sanofi Pays to Get Back Into Oncology
An Irresponsible Statement About Curing Cancer
Oliver Sacks on Turning Back to Chemistry